Annual Current Liabilities
$730.60 K
-$268.00 K-26.84%
December 31, 2023
Summary
- As of February 7, 2025, PCSA annual total current liabilities is $730.60 thousand, with the most recent change of -$268.00 thousand (-26.84%) on December 31, 2023.
- During the last 3 years, PCSA annual current liabilities has fallen by -$490.40 thousand (-40.16%).
- PCSA annual current liabilities is now -71.90% below its all-time high of $2.60 million, reached on December 31, 2017.
Performance
PCSA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$1.22 M
-$332.50 K-21.43%
September 30, 2024
Summary
- As of February 7, 2025, PCSA quarterly total current liabilities is $1.22 million, with the most recent change of -$332.50 thousand (-21.43%) on September 30, 2024.
- Over the past year, PCSA quarterly current liabilities has increased by +$208.50 thousand (+20.63%).
- PCSA quarterly current liabilities is now -57.18% below its all-time high of $2.85 million, reached on March 31, 2018.
Performance
PCSA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PCSA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.8% | +20.6% |
| 3 y3 years | -40.2% | +22.1% |
| 5 y5 years | +13.2% | +22.1% |
PCSA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.8% | at low | -43.6% | +66.9% |
| 5 y | 5-year | -40.2% | at low | -54.1% | +66.9% |
| alltime | all time | -71.9% | +121.0% | -57.2% | +957.4% |
Processa Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.22 M(-21.4%) |
| Jun 2024 | - | $1.55 M(+53.5%) |
| Mar 2024 | - | $1.01 M(+38.3%) |
| Dec 2023 | $730.60 K(-26.8%) | $730.60 K(-11.6%) |
| Sep 2023 | - | $826.10 K(+0.6%) |
| Jun 2023 | - | $821.40 K(-62.0%) |
| Mar 2023 | - | $2.16 M(+116.4%) |
| Dec 2022 | $998.60 K(+2.8%) | $998.60 K(-16.3%) |
| Sep 2022 | - | $1.19 M(-24.1%) |
| Jun 2022 | - | $1.57 M(+48.5%) |
| Mar 2022 | - | $1.06 M(+8.9%) |
| Dec 2021 | $971.00 K(-20.5%) | $971.00 K(-20.8%) |
| Sep 2021 | - | $1.23 M(+5.6%) |
| Jun 2021 | - | $1.16 M(+6.0%) |
| Mar 2021 | - | $1.10 M(-10.3%) |
| Dec 2020 | $1.22 M(+2.5%) | $1.22 M(-54.1%) |
| Sep 2020 | - | $2.66 M(+40.0%) |
| Jun 2020 | - | $1.90 M(+52.3%) |
| Mar 2020 | - | $1.25 M(+4.6%) |
| Dec 2019 | $1.19 M(+84.5%) | $1.19 M(+308.5%) |
| Sep 2019 | - | $291.70 K(-62.8%) |
| Jun 2019 | - | $783.40 K(+8.1%) |
| Mar 2019 | - | $724.70 K(+12.2%) |
| Dec 2018 | $645.70 K | $645.70 K(-6.6%) |
| Sep 2018 | - | $691.20 K(+6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $649.60 K(-77.2%) |
| Mar 2018 | - | $2.85 M(+9.5%) |
| Dec 2017 | $2.60 M(+10.4%) | $2.60 M(+2154.8%) |
| Sep 2017 | - | $115.30 K(-95.4%) |
| Jun 2017 | - | $2.49 M(+2.2%) |
| Mar 2017 | - | $2.44 M(+3.6%) |
| Dec 2016 | $2.35 M(+13.0%) | $2.35 M(+3.1%) |
| Sep 2016 | - | $2.28 M(+3.2%) |
| Jun 2016 | - | $2.21 M(+2.2%) |
| Mar 2016 | - | $2.17 M(+4.0%) |
| Dec 2015 | $2.08 M(+146.8%) | $2.08 M(-0.3%) |
| Sep 2015 | - | $2.09 M(-0.2%) |
| Jun 2015 | - | $2.09 M(+21.6%) |
| Mar 2015 | - | $1.72 M(+104.0%) |
| Dec 2014 | $843.90 K(-24.8%) | $843.90 K(+4.2%) |
| Sep 2014 | - | $809.50 K(+44.1%) |
| Jun 2014 | - | $561.70 K(-28.4%) |
| Mar 2014 | - | $784.50 K(-30.1%) |
| Dec 2013 | $1.12 M(+56.7%) | $1.12 M(-14.4%) |
| Sep 2013 | - | $1.31 M(-44.6%) |
| Jun 2013 | - | $2.36 M(+115.0%) |
| Mar 2013 | - | $1.10 M(+53.7%) |
| Dec 2012 | $715.70 K(+116.5%) | $715.70 K(+295.2%) |
| Sep 2012 | - | $181.10 K |
| Dec 2011 | $330.60 K | - |
FAQ
- What is Processa Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual current liabilities year-on-year change?
- What is Processa Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly current liabilities year-on-year change?
What is Processa Pharmaceuticals annual total current liabilities?
The current annual current liabilities of PCSA is $730.60 K
What is the all time high annual current liabilities for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual total current liabilities is $2.60 M
What is Processa Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, PCSA annual total current liabilities has changed by -$268.00 K (-26.84%)
What is Processa Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of PCSA is $1.22 M
What is the all time high quarterly current liabilities for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly total current liabilities is $2.85 M
What is Processa Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, PCSA quarterly total current liabilities has changed by +$208.50 K (+20.63%)